Severe multisystem inflammatory syndrome (MIS-C/A) after confirmed SARS-CoV-2 infection: a report of four adult cases.

M SansoneM StudahlS BergMagnus GisslenN Sundell

Published in: Infectious diseases (London, England) (2022)

MIS-C/A should be considered, irrespective of age, in patients with fever, hyperinflammation and multiple organ system involvements emerging weeks after COVID-19. Previously suggested treatment regimens for MIS-C seem to be applicable also for MIS-A.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
oxidative stress
early onset
young adults
drug induced
preterm birth